1. MARKETS
  2. SECTOR : BANKING AND FINANCE
  3. INDUSTRY : INVESTMENT TRUSTS/MUTUAL FUNDS
  4. TEKLA HEALTHCARE OPPORTUNITIES FUND

Tekla Healthcare Opportunities Fund

XNYS: THQ

Watchlist

Portfolio

Share


Insider Trading disclosures for Tekla Healthcare Opportunities Fund

The latest disclosure was made by Rose DiMartino in Tekla Healthcare Opportunities Fund where a trade of 1,000 Common Stock done at an average price of $21.3 was reported to US exchanges on July 16, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Rose DiMartino Director Purchase of securities on an exchange or from another person at price $ 21.30 per share. 16 Jul 2024 1,000 1,000 (0%) 0% 21.3 21,300 Common Stock
Kathleen L. Goetz Director Purchase of securities on an exchange or from another person at price $ 19.54 per share. 09 Apr 2024 600 1,148 (0%) 0% 19.5 11,723 Common Stock
Reit Todd Director Purchase of securities on an exchange or from another person at price $ 18.44 per share. 02 Jan 2024 1,000 1,000 (0%) 0% 18.4 18,436 Common Stock
William Maher C. Director Purchase of securities on an exchange or from another person at price $ 18.25 per share. 28 Dec 2023 1,000 1,000 (0%) 0% 18.3 18,250 Common Stock
Kathleen Goetz Director Purchase of securities on an exchange or from another person at price $ 21.74 per share. 23 Mar 2022 69 548 (0%) 0% 21.7 1,500 Shares of Beneficial Interest
Kathleen Goetz Director Purchase of securities on an exchange or from another person at price $ 21.73 per share. 26 Jan 2022 479 479 (0%) 0% 21.7 10,409 Shares of Beneficial Interest
William S. Reardon Director Purchase of securities on an exchange or from another person at price $ 20.85 per share. 25 Feb 2021 1,196 1,196 (0%) 0% 20.9 24,937 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 14.67 per share. 17 Mar 2020 7,300 31,202 (0%) 0% 14.7 107,103 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 17.43 per share. 25 Oct 2018 6,000 23,902 (0%) 0% 17.4 104,580 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 18.19 per share. 17 Oct 2018 5,902 17,902 (0%) 0% 18.2 107,374 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 17.59 per share. 11 Oct 2018 5,500 12,000 (0%) 0% 17.6 96,760 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 18.27 per share. 10 Oct 2018 5,500 6,500 (0%) 0% 18.3 100,467 Shares of Beneficial Interest
Thomas M. Kent None Purchase of securities on an exchange or from another person at price $ 18.50 per share. 25 Jan 2018 1,400 1,400 (0%) 0% 18.5 25,903 Shares of Beneficial Interest
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters